I. Related cell sub types
ID | Name | Number of studies  | |
|---|---|---|---|
| CL_0000066 | epithelial cell | 48 | |
| CL_4030024 | hillock cell | 3 |
ID | Name | Number of studies | |
|---|---|---|---|
| CL_0000066 | epithelial cell | 48 | |
| CL_4030024 | hillock cell | 3 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
|---|---|---|---|---|---|
| DSC3 | 3 | 26% ± 3% | 0 | 3 | |
| KRT13 | 3 | 52% ± 3% | 1 | 4 | |
| KRT15 | 3 | 39% ± 6% | 1 | 6 | |
| TMPRSS4 | 3 | 35% ± 15% | 1 | 8 | |
| TRIM29 | 3 | 40% ± 6% | 1 | 8 | |
| LAMB3 | 3 | 27% ± 9% | 1 | 10 | |
| MUC4 | 3 | 35% ± 12% | 1 | 12 | |
| EHF | 3 | 32% ± 18% | 1 | 15 | |
| TSPAN1 | 3 | 33% ± 13% | 1 | 16 | |
| KRT5 | 3 | 68% ± 35% | 2 | 6 | |
| KRT17 | 3 | 58% ± 31% | 2 | 8 | |
| PPL | 3 | 29% ± 10% | 2 | 10 | |
| CLDN1 | 3 | 36% ± 7% | 2 | 12 | |
| MPZL2 | 3 | 39% ± 12% | 2 | 13 | |
| SFN | 3 | 65% ± 31% | 2 | 15 | |
| GPX2 | 3 | 50% ± 13% | 3 | 11 | |
| S100A2 | 3 | 71% ± 39% | 3 | 15 | |
| SDC1 | 3 | 49% ± 7% | 3 | 20 | |
| KLF5 | 3 | 61% ± 8% | 3 | 23 | |
| S100P | 3 | 30% ± 10% | 4 | 17 | |
| C19orf33 | 3 | 44% ± 18% | 4 | 21 | |
| SPINT1 | 3 | 24% ± 10% | 4 | 22 | |
| ELF3 | 3 | 61% ± 7% | 4 | 32 | |
| MYOF | 3 | 44% ± 12% | 4 | 34 |
| GO_0010466 | Biological process | negative regulation of peptidase activity |
| GO_0042270 | Biological process | protection from natural killer cell mediated cytotoxicity |
| Cell type name | hillock cell |
| Synonyms | |
| Description | An epithelial, transitional cell type between basal and secretory; located in stratified, non-ciliated structures (called hillocks) with high cell turnover in epithelium. In some mammalian species, this cell type has been noted to express KRT13 and is postulated to play a role in squamous barrier function and immunomodulation. |
| Parent | CL_0000066 |
